RAD
Rite Aid Corporation
Set alert
52-week range unavailable
- Open
- 0.7615
- Prev close
- 0.6483
- Mkt cap
- 36.76M
- Vol
- 2.43M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.645
- High
- 0.80
- Forward P/E
- -0.23
- Beta
- 1.29
- Short ratio
- 2.68
- Inst. own
- 49.34%
- Dividend
- 0.00
- Ex-div date
- Oct 13, 1999
- Earnings
- Oct 19, 2023
- 50-d avg
- 0.63458
- 200-d avg
- 1.95
- 1y target
- 1.00
Key statistics
- Market cap
- 36.76M
- Enterprise value
- 6.08B
- Trailing P/E
- 0.00
- Forward P/E
- -0.23
- PEG ratio
- 0.01
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- -14.34
- Beta
- 1.29
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -3.99%
- Revenue (TTM)
- 23.73B
- Revenue growth
- -6.00%
- Free cash flow
- -39.43M
- Total cash
- 140.17M
- Total debt
- 6.18B
- Return on equity
- 0.00%
- Shares outstanding
- 56.70M
- Short % of float
- 32.13%
- 50-day average
- 0.63458
- 200-day average
- 1.95
Analyst view
Consensus: underperform
- Strong buy0
- Buy1
- Hold7
- Sell0
- Strong sell0
Next earnings
Oct 19, 2023
Expected Oct 19, 2023. Consensus EPS estimate -1.71.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 19, 2023 | Aug 1, 2023 | -1.35 | — | — | — |
| Jun 29, 2023 | May 1, 2023 | -1.49 | — | — | — |
| Apr 20, 2023 | Feb 1, 2023 | -0.77 | — | — | — |
| Dec 21, 2022 | Nov 1, 2022 | -0.32 | — | — | — |
| Sep 29, 2022 | Aug 1, 2022 | -0.46 | — | — | — |
| Jun 23, 2022 | May 1, 2022 | -0.70 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 26, 2023 | Deutsche Bank | main | — | Sell |
| Oct 2, 2022 | Deutsche Bank | main | — | Sell |
| Sep 29, 2022 | Evercore ISI Group | main | — | Underperform |
| Jun 2, 2022 | Deutsche Bank | main | — | Sell |
| Apr 6, 2022 | Deutsche Bank | down | Hold | Sell |
| Jun 24, 2021 | JP Morgan | down | Neutral | Underweight |
About Rite Aid Corporation
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and seasonal merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. In addition, it offers its products through online retail site. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Country
- United States
- Website
- riteaid.com
News
- AITX's RAD Announces Additional Healthcare and Construction Orders as Customers Expand Deployments
- RAD Amplify Appoints John King as Senior Vice President, Head of Marketing
- Recludix Pharma to Present Preclinical Asthma and Dermatitis Data for Oral STAT6 Inhibitor REX-8756 at the European Association of Allergy and Clinical Immunology (EAACI) and Revolutionizing Atopic Dermatitis (RAD) Congresses
- Rite Aid closing 114 more stores across multiple states
- Rite Aid Prepares to Sell Remaining Assets
- Home Decor Retailer Expected To File For Bankruptcy: Report
- Unlike CVS, Walgreens Only Interested In Rite Aid Patient Files
- Rite Aid Closing Stores and Selling Pharmacy Assets to Rivals
- Rite Aid sells 1K pharmacies to rivals — including CVS, Walgreens — after second bankruptcy filing
- Rite Aid To Sell Pharmacy Assets From More Than 1,000 Stores To CVS, Walgreens And Grocers
Your note
Sign in to keep a note on RAD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BODAKEN BRUCE G | Director | Stock Award(Grant) | Jul 26, 2022 | 68,458 |
| DONIGAN HEYWARD R | Chief Executive Officer | Stock Award(Grant) | Jul 26, 2022 | 942,611 |
| GILBERT PAUL D | General Counsel | Stock Award(Grant) | Jul 26, 2022 | 111,883 |
| KAZMAIER JESSICA | Officer | Stock Award(Grant) | Apr 24, 2023 | 101,967 |
| KNOWLING ROBERT E JR | Director | Stock Award(Grant) | Jul 26, 2022 | 61,996 |
| MENNEN JUSTIN L. | Chief Technology Officer | Stock Award(Grant) | Apr 24, 2023 | 145,488 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Charles Schwab Investment Management, Inc. | 7.03% | 3,986,565 | 6.02M | Jun 29, 2023 |
| Vanguard Group Inc | 5.11% | 2,895,724 | 4.37M | Jun 29, 2023 |
| Renaissance Technologies, LLC | 3.45% | 1,957,990 | 2.96M | Jun 29, 2023 |
| GMT Capital Corp | 2.61% | 1,482,101 | 2.24M | Jun 29, 2023 |
| Blackrock Inc. | 2.04% | 1,155,401 | 1.74M | Jun 29, 2023 |
| Susquehanna International Group, LLP | 1.13% | 643,221 | 971.26K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Schwab Strategic Tr-Schwab Fundamental U.S. Small Company Index ETF | 4.51% | 2,558,637 | 4.58M | May 30, 2023 |
| Vanguard Total Stock Market Index Fund | 3.52% | 1,996,707 | 3.02M | Jun 29, 2023 |
| Vanguard Extended Market Index Fund | 1.42% | 802,574 | 1.21M | Jun 29, 2023 |
| Schwab Capital Trust-Schwab U.S. Fundamental Small Co Index Fund | 1.32% | 749,507 | 1.21M | Jul 30, 2023 |
| Bridgeway Funds Inc-Small Cap Value Fund | 0.51% | 288,200 | 435.18K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.48% | 274,625 | 491.58K | May 30, 2023 |